ZVRA Q2 2022 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ZVRAZevra Therapeutics, Inc.

$618M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-89.2% YoY

Gross Profit

$1M96.1% margin

Operating Income

-$25M-1905.2% margin

Net Income

-$24M-1849.4% margin

EPS (Diluted)

$-0.70

QoQ Revenue Growth

-67.2%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$124M

Total Liabilities

$25M

Stockholders' Equity

$99M

Cash & Equivalents

$77M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$12M	-89.2%
Gross Profit	$1M	$11M	-88.6%
Operating Income	-$25M	$6M	-524.6%
Net Income	-$24M	$6M	-487.6%